• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>DRS

DRS

  1. All
  2. 3rd Party
  3. Investing
  1. New Global Energy Announces the Addition of Drs . John and Susan Woods of Cellulose Systems, Inc. to Advisory Board

    New Global Energy Announces the Addition of Drs . John and Susan Woods of Cellulose Systems, Inc. to Advisory Board

  2. BAE Systems Awarded Contract to Begin Armored Multi-Purpose Vehicle Program

    BAE Systems Awarded Contract to Begin Armored Multi-Purpose Vehicle Program

  3. Depositary Receipt Capital Raising More Than Triples in 2014 to Highest Level since Financial Crisis

    Depositary Receipt Capital Raising More Than Triples in 2014 to Highest Level since Financial Crisis

  4. Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients

    Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients

  5. Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

    Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

  6. Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

    Longer Follow-Up IMBRUVICA® (ibrutinib) Treatment Demonstrates Sustained Efficacy in Patients with Difficult-to-Treat Chronic Lymphocytic Leukemia (CLL)

  7. Aviation Students: Grants Available to Attend 2015 CHC Safety & Quality Summit

    Aviation Students: Grants Available to Attend 2015 CHC Safety & Quality Summit

  8. Roger Ibbotson, Benoit Mandelbrot, and George Cooper

    Our distinguished economics panel debates the value of current risk models.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.